A Phase 1b/2 Multicenter, Open-label Study to Evaluate the Safety and Efficacy of TTI-101 as Monotherapy and in Combination in Participants with Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
CTRC Inpatient
University of Colorado Hospital
Principal Investigator
![Photograph of Sarah Davis](https://som.ucdenver.edu/FIMS/Content/faculty/22561/CU-Doctors-22561.jpg)
Sarah Davis
Study ID
Protocol Number: 22-1621
More information available at ClinicalTrials.gov: NCT05440708
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers